Post‐radiation middle ear effusion in NPC patients: Analysis of patient, tumour, and radiation factors
Clinical Otolaryngology · 2024
DOI: 10.1111/coa.14159 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Otolaryngology, 2024. Verfasst von Igor Vainer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, Rabin Medical Center, Petah Tikva, Israel. Hauptthemen laut MEDLINE: Nasopharyngeal Neoplasms, Otitis Media with Effusion, Nasopharyngeal Carcinoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
The purpose of this study was to investigate whether patient, tumour and radiation therapy factors are associated with development of middle ear effusion (MEE) in nasopharyngeal carcinoma (NPC) patients. Deign, Settings, and Participants A retrospective review of NPC patients treated between January 2000 and June 2018 at Rabin Medical Center. Patient factors, tumour factors, radiation doses, and radiation fields were collected and outlined if needed (middle ear, eustachian tube [ET], tensor veli palatini [TVP], and levator palatini [LVP] muscles), then analysed and compared between patients with MEE and those without and between sides in patients with unilateral MEE. Main Outcome Measures and Results Seventy‐three patients were enrolled. Most were males (71.2%) with advanced‐stage diseases (78%). At the time of diagnosis 14 patients (19.2%) presented with MEE. Following radiation, 18 patients, with no evidence of MEE at presentation, developed MEE. Tumour stage, histology, and laterality were not associated with development of MEE. Comparison of mean radiation field dosages including—gross target volume, clinical target volume, and patient target volume showed no association with post‐radiation MEE. In addition, no difference was found in the radiation doses to the middle ear, ET or the LVP nor the TVP between ears with and without MEE.
Conclusions
Post‐irradiation MEE remains a common adverse effect in NPC patients. Surprisingly, tumour stage, tumour laterality, and histology were not associated with MEE. Similar findings were observed for total radiation doses and specific doses to the middle ear, ET, and ET muscles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology Head and Neck Surgery, Rabin Medical Center, Petah Tikva, Israel.
- Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel.
- Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem, Israel.
ORCID-Profile: Igor Vainer, Sharon Tzelnick
Zitieren
APA
Vainer, I., Tzelnick, S., Kurman, N., Popovtzer, A., & Soudry, E. (2024). Post‐radiation middle ear effusion in NPC patients: Analysis of patient, tumour, and radiation factors. Clinical Otolaryngology. https://doi.org/10.1111/coa.14159
Vancouver
Vainer I, Tzelnick S, Kurman N, Popovtzer A, Soudry E. Post‐radiation middle ear effusion in NPC patients: Analysis of patient, tumour, and radiation factors. Clinical Otolaryngology. 2024. doi:10.1111/coa.14159
BibTeX
@article{Vainer2024,
author = {Vainer, Igor and Tzelnick, Sharon and Kurman, Noga and Popovtzer, Aron and Soudry, Ethan},
title = {Post‐radiation middle ear effusion in NPC patients: Analysis of patient, tumour, and radiation factors},
journal = {Clinical Otolaryngology},
year = {2024},
doi = {10.1111/coa.14159}
}
EUVIMED